胰岛淀粉样多肽在神经血管单元中的作用机制研究进展
Advances in Research on the Mechanisms of Islet Amyloid Polypeptide in the Neurovascular Unit
DOI: 10.12677/acm.2024.1492432, PDF,    科研立项经费支持
作者: 徐 畅, 万依玲, 王 鑫, 赵 薇*:大理大学第一附属医院眼科,云南 大理
关键词: 胰岛淀粉样多肽神经血管单元脑血管病综述Islet Amyloid Polypeptide Neurovascular Unit Cerebrovascular Disease Review
摘要: 胰岛淀粉样多肽(Islet amyloid polypeptide, IAPP)是由胰岛β细胞产生,并与胰岛素协同分泌的一种激素。正常结构的单体IAPP对于神经血管单元(Neurovascular unit, NVU)产生正面影响。而胰岛素抵抗、肥胖和衰老等原因产生的错误折叠的IAPP,对NVU产生了各种不利的影响。在神经系统中错误折叠的IAPP聚集后通过激活多种信号通路、诱导氧化应激、激活炎症反应、影响细胞调控因子等多种机制,直接损害神经元和胶质细胞的形态和存活率使其结构塌陷功能丧失等。在脑血管系统中,错误折叠的IAPP沉积在血管壁和脑实质形成栓子,进而造成脑血管狭窄,灌注不足甚至出血;激活缺氧信号通路导致微血管功能障碍,病理性红细胞生成增多,血管平滑肌张力增加;损伤人脑血管周细胞正常功能等。错误折叠的IAPP通过以上病理过程加重脑栓塞、脑缺氧缺血发生并影响脑血管病后NVU的重建。综上所述,IAPP通过多种途径和分子机制影响了NVU中不同细胞类型,导致神经损伤,血管功能障碍,最终引发和加重脑血管疾病。深入研究IAPP在NVU中的作用机制对于理解脑血管病的发病机制、开发新的治疗策略及疾病预后的预测具有重要意义。
Abstract: Islet amyloid polypeptide (IAPP) is a hormone produced by pancreatic β-cells and co-secreted with insulin. Monomeric IAPP with a normal structure has a positive impact on the neurovascular unit (NVU). However, misfolded IAPP, resulting from factors such as insulin resistance, obesity, and aging, has various detrimental effects on the NVU. In the nervous system, misfolded IAPP aggregates and activates multiple signaling pathways, induces oxidative stress, triggers inflammatory responses, and affects cellular regulatory factors. These mechanisms directly damage the morphology and survival rates of neurons and glial cells, causing structural collapse and functional loss. In the cerebrovascular system, misfolded IAPP deposits in the vascular walls and brain parenchyma, forming emboli that lead to vascular narrowing, insufficient perfusion, and even hemorrhage. It also activates hypoxia signaling pathways, resulting in microvascular dysfunction, increased pathological erythropoiesis, and enhanced vascular smooth muscle tension. Additionally, it impairs the normal function of human brain pericytes. Through these pathological processes, misfolded IAPP exacerbates cerebral embolism and cerebral hypoxia-ischemia, affecting the reconstruction of the NVU after cerebrovascular disease. In summary, IAPP influences different cell types within the NVU through various pathways and molecular mechanisms, leading to neuronal damage and vascular dysfunction, ultimately triggering and worsening cerebrovascular diseases. In-depth research into the role of IAPP in the NVU is crucial for understanding the pathogenesis of cerebrovascular diseases, developing new therapeutic strategies, and predicting disease prognosis.
文章引用:徐畅, 万依玲, 王鑫, 赵薇. 胰岛淀粉样多肽在神经血管单元中的作用机制研究进展[J]. 临床医学进展, 2024, 14(9): 83-89. https://doi.org/10.12677/acm.2024.1492432

参考文献

[1] Kugler, E.C., Greenwood, J. and MacDonald, R.B. (2021) The “Neuro-Glial-Vascular” Unit: The Role of Glia in Neurovascular Unit Formation and Dysfunction. Frontiers in Cell and Developmental Biology, 9, Article ID: 732820. [Google Scholar] [CrossRef] [PubMed]
[2] Höppener, J.W.M., Ahrén, B. and Lips, C.J.M. (2000) Islet Amyloid and Type 2 Diabetes Mellitus. New England Journal of Medicine, 343, 411-419. [Google Scholar] [CrossRef] [PubMed]
[3] Mathiesen, D.S., Lund, A., Vilsbøll, T., Knop, F.K. and Bagger, J.I. (2021) Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. Frontiers in Endocrinology, 11, Article ID: 617400. [Google Scholar] [CrossRef] [PubMed]
[4] Menezes, R., Martins, I., Ferreira, S. and Raimundo, A. (2021) Islet Amyloid Polypeptide & Amyloid Beta Peptide Roles in Alzheimer’s Disease: Two Triggers, One Disease. Neural Regeneration Research, 16, 1127-1130. [Google Scholar] [CrossRef] [PubMed]
[5] Banks, W.A., Sharma, P., Bullock, K.M., Hansen, K.M., Ludwig, N. and Whiteside, T.L. (2020) Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. International Journal of Molecular Sciences, 21, Article No. 4407. [Google Scholar] [CrossRef] [PubMed]
[6] Zhang, N., Xing, Y., Yu, Y., Liu, C., Jin, B., Huo, L., et al. (2020) Influence of Human Amylin on the Membrane Stability of Rat Primary Hippocampal Neurons. Aging, 12, 8923-8938. [Google Scholar] [CrossRef] [PubMed]
[7] Burillo, J., Fernández-Rhodes, M., Piquero, M., López-Alvarado, P., Menéndez, J.C., Jiménez, B., et al. (2021) Human Amylin Aggregates Release within Exosomes as a Protective Mechanism in Pancreatic β Cells: Pancreatic β-Hippocampal Cell Communication. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1868, Article ID: 118971. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, Y. and Westermark, G.T. (2021) The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level. International Journal of Molecular Sciences, 22, Article No. 11153. [Google Scholar] [CrossRef] [PubMed]
[9] Al Adem, K., Shanti, A., Srivastava, A., Homouz, D., Thomas, S.A., Khair, M., et al. (2022) Linking Alzheimer’s Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates. Frontiers in Molecular Biosciences, 9, Article ID: 842582. [Google Scholar] [CrossRef] [PubMed]
[10] Bharadwaj, P., Solomon, T., Sahoo, B.R., Ignasiak, K., Gaskin, S., Rowles, J., et al. (2020) Amylin and Beta Amyloid Proteins Interact to Form Amorphous Heterocomplexes with Enhanced Toxicity in Neuronal Cells. Scientific Reports, 10, Article No. 10356. [Google Scholar] [CrossRef] [PubMed]
[11] Nakamura, T., Oh, C., Zhang, X. and Lipton, S.A. (2021) Protein S-Nitrosylation and Oxidation Contribute to Protein Misfolding in Neurodegeneration. Free Radical Biology and Medicine, 172, 562-577. [Google Scholar] [CrossRef] [PubMed]
[12] Roham, P.H., Save, S.N. and Sharma, S. (2022) Human Islet Amyloid Polypeptide: A Therapeutic Target for the Management of Type 2 Diabetes Mellitus. Journal of Pharmaceutical Analysis, 12, 556-569. [Google Scholar] [CrossRef] [PubMed]
[13] Pinho, J., Quintas-Neves, M., Dogan, I., Reetz, K., Reich, A. and Costa, A.S. (2021) Incident Stroke in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis. Scientific Reports, 11, Article No. 16385. [Google Scholar] [CrossRef] [PubMed]
[14] Iadecola, C. (2017) The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron, 96, 17-42. [Google Scholar] [CrossRef] [PubMed]
[15] Filosa, J.A., Morrison, H.W., Iddings, J.A., Du, W. and Kim, K.J. (2016) Beyond Neurovascular Coupling, Role of Astrocytes in the Regulation of Vascular Tone. Neuroscience, 323, 96-109. [Google Scholar] [CrossRef] [PubMed]
[16] Albariqi, M., Engelsman, S., Eijkelkamp, N. and Höppener, J. (2020) Amyloid Proteins and Peripheral Neuropathy. Cells, 9, Article No. 1553. [Google Scholar] [CrossRef] [PubMed]
[17] Fu, W., Vukojevic, V., Patel, A., Soudy, R., MacTavish, D., Westaway, D., et al. (2017) Role of Microglial Amylin Receptors in Mediating Beta Amyloid (aβ)-Induced Inflammation. Journal of Neuroinflammation, 14, Article No. 199. [Google Scholar] [CrossRef] [PubMed]
[18] Nuñez-Diaz, C., Pocevičiūtė, D., Schultz, N., Welinder, C., Swärd, K. and Wennström, M. (2023) Contraction of Human Brain Vascular Pericytes in Response to Islet Amyloid Polypeptide Is Reversed by Pramlintide. Molecular Brain, 16, Article No. 125. [Google Scholar] [CrossRef] [PubMed]
[19] Ly, H., Verma, N., Wu, F., Liu, M., Saatman, K.E., Nelson, P.T., et al. (2017) Brain Microvascular Injury and White Matter Disease Provoked by Diabetes‐Associated Hyperamylinemia. Annals of Neurology, 82, 208-222. [Google Scholar] [CrossRef] [PubMed]
[20] Srodulski, S., Sharma, S., Bachstetter, A.B., Brelsfoard, J.M., Pascual, C., Xie, X.S., et al. (2014) Neuroinflammation and Neurologic Deficits in Diabetes Linked to Brain Accumulation of Amylin. Molecular Neurodegeneration, 9, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[21] Castillo, J.J., Aplin, A.C., Hackney, D.J., Hogan, M.F., Esser, N., Templin, A.T., et al. (2022) Islet Amyloid Polypeptide Aggregation Exerts Cytotoxic and Proinflammatory Effects on the Islet Vasculature in Mice. Diabetologia, 65, 1687-1700. [Google Scholar] [CrossRef] [PubMed]
[22] Schultz, N., Byman, E. and Wennström, M. (2018) Levels of Retinal IAPP Are Altered in Alzheimer’s Disease Patients and Correlate with Vascular Changes and Hippocampal IAPP Levels. Neurobiology of Aging, 69, 94-101. [Google Scholar] [CrossRef] [PubMed]
[23] Verma, N., Liu, M., Ly, H., Loria, A., Campbell, K.S., Bush, H., et al. (2020) Diabetic Microcirculatory Disturbances and Pathologic Erythropoiesis Are Provoked by Deposition of Amyloid-Forming Amylin in Red Blood Cells and Capillaries. Kidney International, 97, 143-155. [Google Scholar] [CrossRef] [PubMed]
[24] Verma, N., Ly, H., Liu, M., Chen, J., Zhu, H., Chow, M., et al. (2016) Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased Il-1β Synthesis in Brains of Alzheimer’s Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats. Journal of Alzheimers Disease, 53, 259-272. [Google Scholar] [CrossRef] [PubMed]
[25] Schultz, N., Byman, E., Fex, M. and Wennström, M. (2016) Amylin Alters Human Brain Pericyte Viability and NG2 Expression. Journal of Cerebral Blood Flow & Metabolism, 37, 1470-1482. [Google Scholar] [CrossRef] [PubMed]
[26] Uemura, M.T., Maki, T., Ihara, M., Lee, V.M.Y. and Trojanowski, J.Q. (2020) Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia. Frontiers in Aging Neuroscience, 12, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
[27] O’Gallagher, K., Rosentreter, R.E., Elaine Soriano, J., Roomi, A., Saleem, S., Lam, T., et al. (2022) The Effect of a Neuronal Nitric Oxide Synthase Inhibitor on Neurovascular Regulation in Humans. Circulation Research, 131, 952-961. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, X., Yang, R., Bai, W., Xu, X., Bi, F., Hao, Y., et al. (2020) Involvement of Amylin B-H2s-Connexin 43 Signaling Pathway in Vascular Dysfunction and Enhanced Ischemia-Reperfusion-Induced Myocardial Injury in Diabetic Rats. Bioscience Reports, 40, BSR20194154. [Google Scholar] [CrossRef] [PubMed]
[29] Despa, F. and Goldstein, L.B. (2021) Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes. Stroke, 52, e244-e249. [Google Scholar] [CrossRef] [PubMed]
[30] Caruso, G., Fresta, C.G., Lazzarino, G., Distefano, D.A., Parlascino, P., Lunte, S.M., et al. (2018) Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and Hspb5 from Endothelial RBE4 Cells. International Journal of Molecular Sciences, 19, Article No. 3659. [Google Scholar] [CrossRef] [PubMed]